Skip to main content
. 2017 Sep 12;8(44):77872–77882. doi: 10.18632/oncotarget.20845

Table 4. Coexpression of MSLN and CA125 in epithelioid and non-epithelioid malignant pleural mesothelioma.

Epithelioid n = 220 (%) Non-epithelioid* n = 49 (%)
Both MSLN- and CA125-positive 161 (73.2) 14 (28.6)
Only MSLN-positive 45 (20.5) 14 (28.6)
Only CA125-positive 4 (1.8) 2 (4.1)
Both MSLN- and CA125-negative 2 (0.9) 1 (2.0)

*Biphasic or sarcomatoid subtypes

CA125, cancer antigen 125; MSLN, mesothelin